Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Berlin
Clinical trial register · Germany

Clinical Trials in Berlin, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5082 matching records held by the registry are in this view. Synced 17 Nov 2026, 03:18 UTC
5082
Studies in scope
all four open statuses
2886
Recruiting now
open to new participants
989
Lead sponsors
across recruiting studies
Top sites
Berlin 47 Essen 32 Hamburg 31 Leipzig 23 Dresden 22

Trials with a site in Berlin

47 of 5082 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Not yet open
Eli Lilly and Company
Phase 3
3,000
Berlin, Bochum, Elsterwerda, Frankfurt, Lübeck, Mannheim, Offenbach, Oldenburg
2026-12
Not yet open
Eli Lilly and Company
Phase 3
2,115
Berlin, Bochum, Cologne, Essen, Gladbeck, Hamburg, Leipzig, Lübeck
2026-12
Recruiting
Eli Lilly and Company
Phase 3
2,001
Berlin, Bochum, Hanover, Hohenmölsen, Karlsruhe, Leipzig, Obertshausen, Offenbach
2026-08-26
Recruiting
Eli Lilly and Company
Phase 3
1,000
Berlin, Chemnitz, Hamburg, Leipzig, Schwerin
2026-08-14
Recruiting
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
NCT07101328Lymphoma, Non-Hodgkin, B-cell Lymphoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular
Eli Lilly and Company
Phase 1
215
Berlin, München, Münster
2026-05-28
Recruiting
Eli Lilly and Company
Phase 2
600
Bergisch Gladbach, Berlin, Bielefeld, Bochum, Bonn, Bottrop, Bremen, Cottbus
2026-05-13
Recruiting
Eli Lilly and Company
Phase 2
531
Berlin, Dachau, Hamburg, Karlsruhe, Leipzig, Offenbach
2026-05-06
Recruiting
Eli Lilly and Company
Phase 2
60
Berlin, Dachau, Halle, Ludwigshafen, Ulm
2026-05-04
Recruiting
Eli Lilly and Company
Phase 2
60
Berlin, Dachau, Halle, Ludwigshafen, Ulm
2026-05-04
Recruiting
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
NCT07226843Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell, Follicular Lymphoma
Eli Lilly and Company
Phase 1
460
Berlin, Cologne, Essen, Frankfurt am Main
2026-04-17
Recruiting
Eli Lilly and Company
Phase 3
800
Bamberg, Berlin, Essen, Hanover, Karlsruhe, Marburg, Oldenburg, Schwerin
2026-02-10
Recruiting
Eli Lilly and Company
Phase 3
1,000
Aachen, Berlin, Bielefeld, Chemnitz, Mainz, Mannheim, Schwerin, Siegen
2026-02-09
Recruiting
Eli Lilly and Company
Phase 3
800
Berlin, Bottrop, Cologne, Dessau, Donauwörth, Dresden, Erlangen, Essen
2025-12-22
Recruiting
Eli Lilly and Company
Phase 3
1,035
Berlin, Bünde, Essen, Hamburg, Münster, Oldenburg
2025-12-15
Recruiting
Eli Lilly and Company
Phase 1
141
Berlin
2025-12-02
Recruiting
Eli Lilly and Company
Phase 2
252
Berlin, Dachau, Erlangen, Regensburg, Ulm
2025-11-10
Recruiting
Eli Lilly and Company
Phase 3
1,630
Aachen, Berlin, Bonn, Cologne, Dresden, Düsseldorf, Erlangen, Essen
2025-10-22
Recruiting
Eli Lilly and Company
Phase 2
531
Bendorf, Berlin, Essen, Frankfurt, Hamburg, Leipzig, Mainz, Offenbach
2025-10-22
Recruiting
Eli Lilly and Company
Phase 3
1,100
Berlin, Dresden, Hamburg, Mannheim, Offenbach, Schwerin
2025-10-16
Recruiting
Eli Lilly and Company
Phase 3
4,500
Bad Oeynhausen, Berlin, Brandenburg, Dresden, Düsseldorf, Frankfurt, Hanover, Heidelberg
2025-10-15
Recruiting
Eli Lilly and Company
Phase 3
1,100
Berlin, Dresden, Hamburg, Mannheim, Offenbach, Schwerin
2025-10-15
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Aachen, Bad Homburg, Berlin, Dresden, Essen, Frankfurt, Freiburg im Breisgau, Greifswald
2025-09-02
Active, closed
Eli Lilly and Company
Phase 3
487
Bad Homburg, Berlin, Cologne, Dresden, Essen, Leipzig, Oldenburg
2025-04-30
Active, closed
Eli Lilly and Company
Phase 3
974
Bad Homburg, Berlin, Cologne, Dresden, Essen, Leipzig, Oldenburg
2025-04-30
Active, closed
Eli Lilly and Company
Phase 3
487
Bad Homburg, Berlin, Cologne, Dresden, Essen, Leipzig, Oldenburg
2025-04-30
Recruiting
Eli Lilly and Company
Phase 3
700
Berlin, Chemnitz, Cologne, Erfurt, Gauting, Georgsmarienhütte, Großhansdorf, Halle
2025-03-27
Active, closed
Eli Lilly and Company
Phase 2
143
Augsburg, Berlin, Brandenburg an der Havel, Duisburg, Frankfurt am Main, Halle, Hamburg, Hanover
2024-10-10
Active, closed
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
NCT06561685Metastatic Solid Tumor, Advanced Solid Tumor, Non-small Cell Lung Cancer, SMARCA4-Deficient Tumor
Eli Lilly and Company
Phase 1
340
Berlin, Essen, Frankfurt am Main
2024-09-19
Active, closed
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
NCT06586515Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer, Colorectal Cancer
Eli Lilly and Company
Phase 1
630
Berlin, Dresden, Essen, München
2024-09-12
Active, closed
Eli Lilly and Company
Phase 3
10,000
Bad Nauheim, Bad Oeynhausen, Berlin, Bremen, Dortmund, Dresden, Elsterwerda, Essen
2024-04-30
Recruiting
Eli Lilly and Company
Phase 3
510
Berlin, Dresden, Frankfurt am Main, Jena, Lübeck, Sachsen
2024-04-29
Active, closed
Eli Lilly and Company
Phase 3
450
Berlin, Dresden, Frankfurt am Main, Heidelberg, Marburg, Weisbaden
2024-04-26
Active, closed
Eli Lilly and Company
Phase 3
17,300
Aachen, Bad Friedrichshall, Bad Homburg, Berlin, Bielefeld, Cologne, Dresden, Essen
2024-03-05
Recruiting
Eli Lilly and Company
Phase 3
1,264
Berlin, Chemnitz, Cologne, Erfurt, Freiburg im Breisgau, Gauting, Georgsmarienhütte, Großhansdorf
2023-12-21
Recruiting
Eli Lilly and Company
Phase 3
595
Bad Bentheim, Berlin, Dresden, Frankfurt am Main, Hamburg, Mainz, München, Münster
2023-02-27
Active, closed
Eli Lilly and Company
Phase 3
15,374
Bad Homburg, Bad Oeynhausen, Berlin, Dresden, Essen, Frankfurt, Freiburg im Breisgau, Hamburg
2022-10-11
Active, closed
Eli Lilly and Company
Phase 3
8,000
Augsburg, Berlin, Bottrop, Cologne, Dessau, Donauwörth, Dortmund, Düsseldorf
2022-10-04
Active, closed
Eli Lilly and Company
Phase 2
46
Freiburg im Breisgau, Essen, Berlin
2022-09-20
Active, closed
Eli Lilly and Company
Phase 3
101
Freiburg im Breisgau, Sankt Augustin, Sendenhorst, Berlin, Bremen, Hamburg
2021-04-13
Active, closed
Eli Lilly and Company
Phase 3
261
Heidelberg, Gauting, Immenstadt im Allgäu, Georgsmarienhütte, Göttingen, Cologne, Großhansdorf, Berlin
2020-02-17
Recruiting
Eli Lilly and Company
Phase 3
190
Berlin, Hamburg, Heidelberg, Sankt Augustin, Tübingen
2019-04-05
Active, closed
Eli Lilly and Company
Phase 3
1,058
Berlin, Brandenburg, Halle, Hamburg, Hanover, Ludwigshafen
2018-07-18
Active, closed
Eli Lilly and Company
Phase 1
223
Würzburg, Berlin
2016-11-21
Active, closed
Eli Lilly and Company
Phase 2
309
Tübingen, Ulm, Erlangen, Hanover, Berlin, Hamburg
2016-05-19
Active, closed
Eli Lilly and Company
Phase 3
545
Gerlingen, Heidelberg, Cologne, Chemnitz, Halle, Großhansdorf, Berlin
2015-05-06
Active, closed
Eli Lilly and Company
Phase 3
453
Berlin, Gera, Großhansdorf, Hamburg, Hanover, Heidelberg, Immenhausen, Nuremberg
2014-10-03
Rows per page Showing 1–47 of 47
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 November 2026. https://priyalifescience.com/clinical-trials-germany/city/berlin

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,082 studies in total at the last sync on 17 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 47 of those studies with a site in Berlin that also match the filters currently applied.

How many clinical trials are recruiting in Berlin?

25 of the 47 studies on this page are recruiting new participants as of the 17 Nov 2026, 03:18 UTC sync. A further 2 have not yet opened recruitment, 20 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Berlin), 47 studies
PhaseStudiesRecruitingShare
Phase 3321668.1%
Phase 29619.1%
Phase 16312.8%

Most active sponsors

Lead sponsors with the most studies (Berlin)
Lead sponsorStudiesRecruiting
Eli Lilly and Company4725
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.